MyFinsight

HomeAboutContact
Curious boy with magnifying glass
A worm made of letters APL
A worm made of letters BOA

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2024 MyFinsight. All rights reserved.

SWK Holdings Corp (SWKHL)

For the quarter ending 2025-06-30, SWKHL made $10,052K in revenue. $3,536K in net income. Net profit margin of 35.18%.

Overview

Revenue
$10,052K
Net Income
$3,536K
Net Profit Margin
35.18%
EPS
$0.29
Unit: Thousand (K) dollars
Revenue Breakdown
    • Finance receivable interest inco...
    • Pharmaceutical development
    • Finance Receivables Segment
    • Pharmaceutical Development And O...

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
2025-06-30
Total revenues10,052
Pharmaceutical manufacturing, research and development expense645
Provision (benefit) for credit losses761
Interest expense1,155
Loss on impairment of intangibles assets-
General and administrative expense2,843
Depreciation and amortization expense19
Change in fair value of acquisition-related contingent consideration-
Income from operations4,629
Net gain (loss) on marketable investments37
Realized gain on early payment of finance receivable-
Loss on sale of assets-
Realized and unrealized foreign currency transaction gains (losses)-451
Gain (loss) on revaluation of finance receivables-
Net gain on exercise and cancellation of warrants-
Unrealized net gain (loss) on warrants347
Income before income tax expense4,562
Income tax expense1,026
Net income3,536
Basic (in dollars per share)0.29
Basic (in shares)12,208,000
Diluted (in dollars per share)0.29
Diluted (in shares)12,208,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement

DownloadDownload image
Finance ReceivablesSegment$250K Pharmaceutical Development AndOther Segment$69K Finance receivableinterest income,...$8,543K Other$319K Pharmaceutical development$1,190K Total revenues$10,052K Net gain (loss) onmarketable investments$37K Income from operations$4,629K Unrealized net gain (loss)on warrants$347K Depreciation andamortization expense$19K General andadministrative expense$2,843K Interest expense$1,155K Provision (benefit) forcredit losses$761K Pharmaceutical manufacturing,research and development...$645K Income before incometax expense$4,562K Realized and unrealizedforeign currency...-$451K Net income$3,536K Income tax expense$1,026K